97 related articles for article (PubMed ID: 12913719)
1. Prostatic and peripheral blood selenium levels after oral supplementation.
Gianduzzo TR; Holmes EG; Tinggi U; Shahin M; Mactaggart P; Nicol D
J Urol; 2003 Sep; 170(3):870-3. PubMed ID: 12913719
[TBL] [Abstract][Full Text] [Related]
2. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
[TBL] [Abstract][Full Text] [Related]
3. Selenium level in benign and cancerous prostate.
Zachara BA; Szewczyk-Golec K; Wolski Z; Tyloch J; Skok Z; Bloch-Boguslawska E; Wasowicz W
Biol Trace Elem Res; 2005 Mar; 103(3):199-206. PubMed ID: 15784953
[TBL] [Abstract][Full Text] [Related]
4. Selenium levels of patients with newly diagnosed prostate cancer compared with control group.
Lipsky K; Zigeuner R; Zischka M; Schips L; Pummer K; Rehak P; Hubmer G
Urology; 2004 May; 63(5):912-6. PubMed ID: 15134980
[TBL] [Abstract][Full Text] [Related]
5. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Sabichi AL; Lee JJ; Taylor RJ; Thompson IM; Miles BJ; Tangen CM; Minasian LM; Pisters LL; Caton JR; Basler JW; Lerner SP; Menter DG; Marshall JR; Crawford ED; Lippman SM
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2178-84. PubMed ID: 16609032
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
[TBL] [Abstract][Full Text] [Related]
7. Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia.
Zachara BA; Szewczyk-Golec K; Tyloch J; Wolski Z; Szylberg T; Stepien S; Kwiatkowski S; Bloch-Boguslawska E; Wasowicz W
Neoplasma; 2005; 52(3):248-54. PubMed ID: 15875088
[TBL] [Abstract][Full Text] [Related]
8. Selenium and selenomethionine levels in prostate cancer patients.
Nyman DW; Suzanne Stratton M; Kopplin MJ; Dalkin BL; Nagle RB; Jay Gandolfi A
Cancer Detect Prev; 2004; 28(1):8-16. PubMed ID: 15041072
[TBL] [Abstract][Full Text] [Related]
9. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
10. Are men with low selenium levels at increased risk of prostate cancer?
Brinkman M; Reulen RC; Kellen E; Buntinx F; Zeegers MP
Eur J Cancer; 2006 Oct; 42(15):2463-71. PubMed ID: 16945521
[TBL] [Abstract][Full Text] [Related]
11. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
[TBL] [Abstract][Full Text] [Related]
12. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.
van den Brandt PA; Zeegers MP; Bode P; Goldbohm RA
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):866-71. PubMed ID: 14504196
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
[TBL] [Abstract][Full Text] [Related]
14. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
[TBL] [Abstract][Full Text] [Related]
15. Selenium glycinate supplementation increases blood glutathione peroxidase activities and decreases prostate-specific antigen readings in middle-aged US men.
Zhang W; Joseph E; Hitchcock C; DiSilvestro RA
Nutr Res; 2011 Feb; 31(2):165-8. PubMed ID: 21419321
[TBL] [Abstract][Full Text] [Related]
16. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
Marks LS; Roehrborn CG; Wolford E; Wilson TH
J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
[TBL] [Abstract][Full Text] [Related]
17. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
Hernáandez J; Syed S; Weiss G; Fernandes G; von Merveldt D; Troyer DA; Basler JW; Thompson IM
J Urol; 2005 Aug; 174(2):519-22. PubMed ID: 16006884
[TBL] [Abstract][Full Text] [Related]
18. DNA stability and serum selenium levels in a high-risk group for prostate cancer.
Karunasinghe N; Ryan J; Tuckey J; Masters J; Jamieson M; Clarke LC; Marshall JR; Ferguson LR
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):391-7. PubMed ID: 15006914
[TBL] [Abstract][Full Text] [Related]
19. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
[TBL] [Abstract][Full Text] [Related]
20. Selenium concentration in the prostate.
Arnold WN; Thrasher JB
Biol Trace Elem Res; 2003 Mar; 91(3):277-80. PubMed ID: 12663951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
